Binding of Mucin by E. coli from Human Gut


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Cells of E. coli isolates from the gut of healthy volunteers (N=5) and patients with Crohn’s disease (N=5) and laboratory E. coli strain DH5α bound mucin in vitro in similar amounts ranging from 0.02 to 0.12 mg/mg of bacterial dry weight. Binding was evaluated by the decrease in optical absorption of mucin solution at 214 nm after incubation with bacteria. Detailed analysis of mucin binding by one of isolates showed that during incubation of 0.09 mg/ml bacteria in 0.15 M NaCl containing 0.1 mg/ml mucin at 25oC, maximum binding was reached in 30 min, while in the presence of 14 mM α-methyl mannoside, mucin binding decreased by 46% (p<0.05). Confocal microscopy revealed intensive binding of FITC-labeled mucin to the surface of a small number of bacterial cells. Mucin binding did not significantly affect zeta potential of bacteria and their energetic status assessed by ATP content; at the same time, ATP content in the extracellular environment slightly increased.

Sobre autores

T. Vakhrusheva

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Rússia, Moscow

Yu. Baikova

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Rússia, Moscow

N. Balabushevich

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Rússia, Moscow

S. Gusev

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Rússia, Moscow

G. Lomakina

Faculty of Chemistry, M. V. Lomonosov Moscow State University

Email: lemik2007@yandex.ru
Rússia, Moscow

E. Sholina

Faculty of Chemistry, M. V. Lomonosov Moscow State University

Email: lemik2007@yandex.ru
Rússia, Moscow

M. Moshkovskaya

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Rússia, Moscow

P. Shcherbakov

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Rússia, Moscow

O. Pobeguts

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Rússia, Moscow

E. Mikhal’chik

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Autor responsável pela correspondência
Email: lemik2007@yandex.ru
Rússia, Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies